|
Mr. Paul Goodson
Quotient Pharmaceuticals Manufacturing Director of Clinical Affairs, Board Member Mr. Goodson has more than 20 years of experience in biotechnology. He has held the top investor relations positions at Sequenom, Anesiva, XOMA, and Invitrogen. Paul also co-founded two biotech companies: Phytogen, a plant genetics company, and the International Biotechnology Company, which worked to develop a single-dose hepatitis B vaccine. Previously, Paul was president, CFO and a Board member of Engine Corporation of America, a developer of advanced diesel and gas turbine engine technologies and president, COO and a Board member of CERAC, an environmental certification laboratory. He has been a Director on the Boards of Quantum Group, an environmental sensor company, and the San Diego National Investor Relations Institute, where he was also Treasurer. He holds degrees in chemical engineering from Caltech and the University of Wisconsin, an MBA from UCLA, and was a Resident Honors Scholar at the University of Southern California. |